Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Applied Therapeutics (APLT) stocks
Learn how to easily invest in Applied Therapeutics stocks.
Applied Therapeutics is a biotechnology business based in the US. Applied Therapeutics stocks (APLT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $24.77 – a decrease of 12.75% over the previous week. Applied Therapeutics employs 26 staff and has a trailing 12-month revenue of around $10.7 million.
How to buy Applied Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – APLT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Applied Therapeutics?
- Has coronavirus impacted Applied Therapeutics shares?
- Applied Therapeutics shares summary
- Compare share dealing platforms
- Is Applied Therapeutics stock a buy or sell?
- Applied Therapeutics performance over time
- Applied Therapeutics's financials
- How volatile are Applied Therapeutics shares?
- Does Applied Therapeutics pay a dividend?
- Other common questions
Applied Therapeutics stock price (NASDAQ:APLT)Use our graph to track the performance of APLT stocks over time.
Applied Therapeutics shares at a glance
|Latest market close||$1.30|
|52-week range||$0.50 - $2.18|
|50-day moving average||$1.19|
|200-day moving average||$1.04|
|Wall St. target price||$7.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.35|
Buy Applied Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Applied Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Applied Therapeutics price performance over time
Historical closes compared with the close of $1.3 from 2023-05-26
|1 week (2023-05-19)||-12.75%|
|1 month (2023-04-28)||-23.53%|
|3 months (2023-02-28)||28.71%|
|6 months (2022-11-28)||44.12%|
|1 year (2022-05-27)||-15.58%|
|2 years (2021-05-27)||-93.35%|
|3 years (2020-05-28)||46.92|
|5 years (2018-05-24)||N/A|
Applied Therapeutics financials
|Revenue TTM||$10.7 million|
|Gross profit TTM||$0|
|Return on assets TTM||-93.08%|
|Return on equity TTM||-366.97%|
|Market capitalisation||$75.2 million|
TTM: trailing 12 months
Applied Therapeutics share dividends
We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.
Applied Therapeutics share price volatility
Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $0.5 up to $2.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 1.8892. This would suggest that Applied Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Applied Therapeutics overview
Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. .
Stocks similar to Applied Therapeutics
Applied Therapeutics in the news
Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency
Applied Therapeutics Reports First Quarter 2023 Financial Results
Applied Therapeutics Reports First Quarter 2023 Financial Results
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
Camera financing in Canada
Compare six ways to finance a camera in Canada, including options for good and bad credit.
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
Personal loans in Saskatchewan up to $50,000
Compare lenders to find the best personal loan in Saskatchewan for your needs.
Compare bad credit loans in Winnipeg
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
Money Management for Teens: 7 Tips from Financial Experts
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.